DSI InPharmatics

DSI InPharmatics is a specialized consultancy providing Chemistry, Manufacturing, and Controls (CMC) and regulatory affairs services to the pharmaceutical and biotechnology industries. The company assists clients in navigating the technical and regulatory hurdles of drug development, offering expertise in drug substance and drug product manufacturing, quality systems, and regulatory submissions. Their team of experts supports a wide range of modalities, including small molecules, biologics, and advanced therapies like cell and gene therapy. In 2021, DSI InPharmatics was acquired by ProductLife Group, a global provider of regulatory and pharmacovigilance services. The firm is headquartered in Pennsylvania and serves a global client base ranging from virtual biotechs to large pharmaceutical companies. DSI is particularly known for its ability to manage complex CMC projects and ensure compliance with global regulatory standards.